A synthetic heparin-mimicking polyanionic compound binds to the LDL receptor-related protein and inhibits vascular smooth muscle cell proliferation

Journal of Cellular Biochemistry

Volumn 81, Issue 1, 2001, Pages 114-127

  Bulseco, Dylan A ^a   Poluha, Wojciech ^a   Schonhoff, Christopher M ^a   Daou, Marie Claire ^a   Condon, Peter J ^a   Ross, Alonzo H ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

Antiproliferative activity; Apolipoprotein E; Cell surface receptors; Heparan sulfate; Heparin mimicking compounds; Lactoferrin; LDL receptor related protein

Indexed keywords

4 HYDROXYPHENOXYACETIC ACID; APOLIPOPROTEIN E3; CARBON 14; CELL SURFACE RECEPTOR; FORMALDEHYDE; HEPARAN SULFATE; HEPARIN; HEPARIN DERIVATIVE; HEPARIN LYASE; IODINE 125; LACTOFERRIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; POLYANION; RG 13577; UNCLASSIFIED DRUG;

ANIMAL CELL; AORTA; ARTICLE; ATHEROSCLEROSIS; CATTLE; CELL PROLIFERATION; CHO CELL; CONTROLLED STUDY; DRUG RECEPTOR BINDING; EMBRYO; HUMAN; HUMAN CELL; IODINATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESTENOSIS; SKIN FIBROBLAST; VASCULAR SMOOTH MUSCLE;

ANIMALS; APOLIPOPROTEINS E; BINDING, COMPETITIVE; CARBON RADIOISOTOPES; CATTLE; CELL DIVISION; CELLS, CULTURED; CHO CELLS; CRICETINAE; FIBROBLASTS; HEPARIN; HEPARIN LYASE; HEYMANN NEPHRITIS ANTIGENIC COMPLEX; IODINE RADIOISOTOPES; MEMBRANE GLYCOPROTEINS; MUSCLE, SMOOTH, VASCULAR; PHENOXYACETATES; POLYMERS;

CRICETINAE; CRICETULUS GRISEUS;

EID: 0035094843     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-4644(20010401)81:1<114::AID-JCB1028>3.0.CO;2-Q     Document Type: Article

References (54)

1. Circulation. Heparan sulfate proteoglycan-mediated uptake of apoliprotein E-triglyceride-rich iipoprotein particles: A major patway at physiological particle concentrations
2. Functional domains in thrombin outside the catalytic site: Cellular interaction
3. Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein
4. Reversal of bFGF autocrine cell transformation by aromatic anionic compounds
5. Antiproliferative activity to vascular smooth muscle cells and receptor binding of heparin-mimicking polyaromatic anionic compounds
6. The metabolism of yew low density lipoprotein proteins
7. The low-density lipoprotein receptor-related protein: Double agent or decoy
8. Receptor-associated protein: A specialized chaperone and antagonist for members of the LDL receptor gene family
9. Inhibition of lymphocyte proliferation by synthetic peptides homologous to plasma apolipoproteins B and E
10. Binding and intenalization of heparin by vascular smooth muscle cells
11. Structural determinants of the capacity of heparin to inhibit the proliferation of vascular smooth muscle cells. II: Evidence for a pentasaccharide sequence that contains a 3-0-sulfate group
12. Preparation and anti-HIV activities of aurintricarboxylic acid fractions and analogues: Direct correlation of antiviral potency with molecular weight
13. Lipoprotein lipase enhances binding of lipoproteins to heparan sulfate on cell surfaces and extracellular matrix
14. Animal cell mutants defective in glycosaminoglycan biosynthesis
15. Inhibition of neoinitmal smooth muscle accumulation after angioplasty by an antibody to PDGF
16. Cellular metabolism of human plasma intermediate-density lipoprotein (IDL)
17. The pathogenesis of cornary artery disease and the acute coronary syndromes
18. Domain closure in lactoferrin. Two hinges produce a see-saw motion between alternative close-packed interfaces
19. Cell surface associated heparin-like molecules are required for the binding of vascular endothelial growth factor (VEGF) to its cell surface receptors
20. Cellular signalling by lipoprotein receptors
21. Apolipoprotein E inhibition of vascular smooth musvle cell proliferation but not the inhibition of migration is mediated through activation of inducible nitric oxide synthase
22. Structures and functions of multiligand lipoprotein receptors: Macrophage scavenger receptors and LDL receptor-related protein (LRP)
23. A single mutation affect both acetylglucosaminyltransferase and glucuronosyltransferase activities in a Chinese hamster ovary cell mutant defective in heparan sulfate biosynthesis
24. Role of basic fibroblast growth factor in vascular lesion formation
25. Purification and characterization of heparin lyases from flavobacterium heparinum
26. Proliferating or interleukin-1 activated human vascular smooth muscle cells secrete copious interleukin-6
27. Apolipoprotein E: From athresclerosis to Alzheimer's disease and beyond
28. Delineation of the glycosaminoglycan-binding site in the human inflammatory response protein lactoferrin
29. Endogenous basic fibroblast growth factor displaced by heparin from the luminal surface of human blood vessels is preferentially sequestered by injured regions of the vessel wall
30. Modulation of fibroblast growth factor-2 receptor binding, dimerization, signaling, and angiogenic activity by a synthetic heparin-mimicking polyanionic compound
31. Functional domains of the receptor-associated protein (RAP)
32. 125I-radiolabeled derivatives of hyaluronic acid uniquely modified at the reducing end
33. Mimicry of biological macromolecules by polyaromatic anionic compounds
34. The pathogenesis of atherosclerosis: A prespective for the 1990s
35. Suramin rapidly alters cellular tyrosine phosphorylation in prostate cancer cell lines
36. Differentiation of coronary smooth muscle cells to a cell cycle arrested hypertrophic growth status by a synthetic non-toxic heparin-mimicking compound
37. The antiproliferative activity of arterial heparan sulfate resides in domains enriched with 2-0-sulfated uronic acid residues
38. Effects of apoprotein E on intracellular metabolism of model triglyceride-rich particles are distinct from effects on cell particle uptake
39. Lipolysis exposes unreactive endogenous apolipoprotein E-3 in human and rat plasma very low density lipoprotein
40. Effect of lipid particle size on association of apolipoproteins with lipid
41. HHF35, a muscle actin specific monoclonal antibody
42. Extracellular matrix-bound growth factors, enzymes and plasma proteins
43. Apolipoprotein E: A petent inhibitor of endothelial and tumor cell proliferation
44. Human apolipoprotein E expression in Escherichia coli: Structural and functional identiy of the bacterially produced protein with plasma apolipoprotein E
45. The low density lipoprotein receptor-related protein mediates the cellular degradation of tissue factor pathway inhibitor
46. The low density lipoprotein receptor gene family: Multiple roles in lipid metabolizm
47. Low density lipoprotein receptor-related protein and gp-330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance
48. Molecular dissection of ligand binding sites on the low density lipoprotein receptor-related protein
49. Heparin supresses the induction of c-fos and c-myc mRNA in murine fibroblast by selective inhibition of a protein kinase C dependent pathway
50. Characterization of the glycosaminoglycan-binding region of lactoferrin
51. Cell surface heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity-receptor
52. Spontaneous hypercholesterolemia and artercal lesions in mice lacking apolipoprotein E
53. Organ distribution in rats of two members of the low density lipoprotein receptor gene family, gp-330 and LRP/alpa2MG, and the receptor-associated protein (RAP)
54. Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells